- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03272815
Percussion Device (PD) for Detection of Pneumothorax
August 16, 2021 updated by: Richard Malthaner, Lawson Health Research Institute
Evaluation of a Novel Point-of-care Percussion Device (PD) for Detection of Pneumothorax in Patients Following Thoracic Surgery
This study aims to examine the safety and efficacy of the Percussion Device in detecting a pneumothorax in patients that have undergone thoracic surgery.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
A prospective, non-randomized clinical feasibility cohort study.
The purpose of this feasibility study is to collect preliminary performance and safety information for the Percussion Device (PD).
Patients satisfying the inclusion criteria will be approached for study enrolment before their surgery in clinic.
Following surgery and after the patient's chest tube has been removed, evaluation of the chest using the PD and ultrasound will be performed by two independent assessors (a nurse practitioner or resident on the Thoracic Surgery Team) prior to the post-removal CXR.
Details of study procedure are details in section 2.8.
The PD's performance metric will be compared against CXR results, which is considered the gold standard in diagnosing a pneumothorax.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 5W9
- London Health Sciences Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients that have undergone an open or thoracoscopic thoracic procedure requiring a chest tube at London Health Sciences Centre (LHSC), London, Ontario.
Exclusion Criteria:
- Patients less than 18 years old Patients unable to consent Patients with known persistent pneumothorax prior to chest tube removal Patients who are pregnant Patients with severe chest wall deformity.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PD arm
Patients undergoing assessment of the chest with the percussion device (PD).
|
A laboratory prototype of the Percussion Device (PD) has been designed and built; laboratory data collection software, signal analysis and classification algorithms have been developed.
It has been designed to detect a pneumothorax.
|
Active Comparator: US arm
Patients undergoing assessment of the chest with the ultrasound (US).
|
The SonoSite hand help portable ultrasound device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Performance metrics
Time Frame: 2 years
|
Performance metrics of the PD in detecting the presence of a pneumothorax following the removal of the last chest tube in patients that have undergone thoracic surgery compared to the CXR reported by a blinded radiologist unaware of the study.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inter-rater reliability
Time Frame: 2 years
|
The secondary outcomes will include inter-rater reliability with the PD or ultrasound or CXR.
|
2 years
|
Adverse Events
Time Frame: 2 years
|
Any adverse event associated with the PD or ultrasound or CXR.
|
2 years
|
Marginal Costs
Time Frame: 2 years
|
Marginal costs differences between the surgeon performed PD and CXR will be based on an overall risk-benefit assessment that will take into account accuracy and costs of facilities as well as physician services.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Richard Malthaner, MD, Lawson Health Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2018
Primary Completion (Actual)
November 1, 2019
Study Completion (Actual)
November 1, 2019
Study Registration Dates
First Submitted
September 2, 2017
First Submitted That Met QC Criteria
September 2, 2017
First Posted (Actual)
September 6, 2017
Study Record Updates
Last Update Posted (Actual)
August 23, 2021
Last Update Submitted That Met QC Criteria
August 16, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 109205
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumothorax
-
Tabriz University of Medical SciencesAJA University of Medical SciencesUnknownPneumothorax, Spontaneous | Pneumothorax Spontaneous Primary | Pneumothorax, Recurrent | Pneumothorax Spontaneous TensionIran, Islamic Republic of
-
Peking University Third HospitalNot yet recruitingPrimary Spontaneous Pneumothorax
-
Rennes University HospitalRecruiting
-
Dow University of Health SciencesUnknownSecondary PneumothoraxPakistan
-
University Hospital, Strasbourg, FranceRecruiting
-
Chinese University of Hong KongRecruitingPneumothorax, SpontaneousHong Kong
-
Johns Hopkins UniversityRecruitingPneumothorax | Tension PneumothoraxUnited States
-
University of RochesterWithdrawn
-
IsalaRecruitingPneumothorax and Air LeakNetherlands
-
Far Eastern Memorial HospitalNational Taiwan University Hospital; Department of HealthUnknown
Clinical Trials on Percussion Device (PD)
-
Vanderbilt University Medical CenterRecruiting
-
University of FloridaRecruitingCystic FibrosisUnited States
-
University of Colorado, DenverCystic Fibrosis Foundation; American Biosystems (currently Hill-Rom)Terminated
-
Penang Hospital, MalaysiaCompletedChronic Obstructive Pulmonary Disease (COPD) | Chronic BronchiectasisMalaysia
-
Istanbul Medipol University HospitalCompletedPregnancy Complications | Physiotherapy | Edema LegTurkey
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaFondazione Salvatore MaugeriUnknownAcute Respiratory Failure
-
Istanbul Medipol University HospitalRecruitingAnterior Cruciate Ligament Injuries | Vibration TherapyTurkey
-
Hospital Universitario Ramon y CajalPhilips HealthcareNot yet recruitingObstructive Sleep Apnea of AdultSpain
-
Riphah International UniversityRecruiting
-
Sehat Medical ComplexCompletedHamstring SprainPakistan